2024-05-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP Chief Patient & Ext Af Off | | $430.93 | $13,790 | +8.26% | |
2024-02-26 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP Chief Patient & Ext Af Off | | $425.70 | $1.28M | +7.17% | |
2024-02-21 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP Chief Patient & Ext Af Off | | $421.77 | $1.35M | +10.65% | |
2024-02-20 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP Chief Patient & Ext Af Off | | $420.79 | $1.79M | +10.34% | |
2024-02-12 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP Chief Patient & Ext Af Off | | $420.24 | $1.35M | +10.7% | |
2023-11-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP Chief Patient & Ext Af Off | | $369.92 | $12,947 | +23.75% | |
2023-08-10 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | | $350.00 | $3.51M | +17.33% | |
2021-11-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | | $187.19 | $9,547 | +44.25% | |
2021-05-17 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | | $216.35 | $9,736 | -4.41% | |
2021-04-27 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | | $216.06 | $839,193 | -4.05% | |
2021-02-25 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | | $213.42 | $765,307 | -2.9% | |
2021-02-18 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | | $211.83 | $1.96M | -1.39% | |
2021-02-11 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | | $210.55 | $939,068 | -1.76% | |
2020-11-16 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | | $223.53 | $9,388 | -6.17% | |
2020-08-03 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | | $278.28 | $540,137 | -22.49% | |
2020-05-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | | $284.41 | $16,496 | -19.72% | |
2020-05-11 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | | $282.61 | $3.01M | -18.47% | |
2020-05-06 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | | $275.28 | $184,162 | -13.36% | |
2020-05-05 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | | $270.01 | $3.61M | -13.89% | |
2020-05-04 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | | $262.28 | $11.48M | -11.37% | |